Belotero and Restylane are families of hyaluronic acid (HA) fillers with products for facial folds, under-eye hollows, lips, and cheeks. This Belotero vs Restylane filler comparison explains where their U.S.-approved uses overlap and where they differ.
The most useful comparison is product-specific. Belotero Balance (+) and Restylane Eyelight both have an under-eye indication, while Restylane Contour has a temple indication that the three U.S. Belotero products discussed here do not.
Belotero vs Restylane Filler Comparison at a Glance
The table summarizes Belotero clinical product information and Galderma’s U.S. Restylane indications. These are examples of approved uses, not a claim that the products produce equivalent results in each area. Current labeling provides the full indications, patient criteria, and injection instructions.
| Treatment goal | Belotero example | Restylane example |
| Moderate to severe facial wrinkles and folds, including nasolabial folds | Balance (+) | Restylane or Restylane-L; other products have their own fold indications |
| Infraorbital hollowing | Balance (+) | Eyelight |
| Lip augmentation | Intense (+) | Silk or Kysse; Restylane and Restylane-L also have lip indications |
| Cheek or midface volume | Volume (+) | Lyft or Contour |
| Temple hollowing | No equivalent indication among Balance (+), Intense (+), and Volume (+) | Contour |
| Specified chin profile correction | No equivalent indication among those three Belotero products | Lyft or Defyne |
Availability note: The FDA approved Belotero Volume (+) in May 2026 and Belotero Intense (+) in July 2026. Merz announced the expanded U.S. Belotero portfolio in September 2026. Anticipated U.S. commercial availability is October 14, 2026 for Volume (+) and December 1, 2026 for Intense (+). Balance (+) is already available. Confirm current availability with Merz or an authorized distributor before planning treatments or placing orders.
How Belotero Compares to Restylane HA Technology
How Belotero compares to Restylane depends on which gels you place side by side. Merz uses CPM technology across the three Belotero products covered here. Galderma’s technology overview groups Restylane Lyft, Silk, and Eyelight with NASHA, and Contour, Kysse, Refyne, and Defyne with XpresHAn. Restylane Contour is therefore a flexible XpresHAn product despite its cheek and temple indications.
Gel technology can help explain why products feel and behave differently, but it cannot replace the product instructions or a clinical assessment. For example, the Belotero Balance (+) instructions specify mid-to-deep dermal injection for moderate to severe facial wrinkles and folds. It would be inaccurate to describe the entire Belotero line as a set of superficial fillers.
Belotero Intense (+) has a lip indication with specified submucosal or subcutaneous placement, while Volume (+) has a deep midface indication.
Belotero: Pros and Limitations
What Stands Out
- The Merz product portfolio includes Belotero. Its U.S. range offers Balance (+) for facial folds and infraorbital hollowing, Intense (+) for lips, and Volume (+) for midface volume in adults 22 and older.
- Merz describes CPM as helping its gels integrate with tissue, a product characteristic worth discussing when the treatment goal calls for subtle correction. This is a manufacturer description, not proof of superiority over a specific Restylane gel.
- Balance (+) and Volume (+) have manufacturer statements of results lasting up to 18 months, subject to the study and treatment-area qualifications behind those claims.
Where It Has Limits
- The three U.S. products listed here do not have the temple or specified chin indications that certain Restylane products hold.
- A family-level description of tissue integration cannot predict an individual result or justify placing every Belotero product in the same tissue plane.
- Duration differs by product and patient. Merz’s up-to-18-month statement for Balance (+) includes a qualification about patients who responded by week eight.
Restylane: Pros and Limitations
What Stands Out
- The U.S. range includes distinct products for folds, lips, under-eye hollows, cheeks, temples, and specified chin uses.
- NASHA and XpresHAn give clinicians different gel characteristics within the same family. Galderma describes the former as firmer and the latter as more flexible.
- Contour has a temple hollowing indication, while Lyft and Defyne have specified chin profile indications.
Where It Has Limits
- A firmer NASHA product should not stand in for the entire range. XpresHAn products address movement and expression, so the usual “Restylane is firm; Belotero is soft” shortcut is misleading.
- A broader portfolio does not guarantee a better result, longer duration, or lower risk for an individual patient.
Belotero Restylane Treatment Areas: Where Do They Overlap?
Belotero and Restylane treatment areas overlap across several common aesthetic goals, including nasolabial folds, infraorbital hollowing, lip augmentation, and cheek or midface correction. The more precise question is which named product addresses the intended area and whether the patient fits its labeling.
Under-Eye Hollows
Belotero Balance (+) and Restylane Eyelight each have a U.S. indication for infraorbital hollowing. This does not make them interchangeable.
Under-eye anatomy, skin characteristics, prior filler, and the planned degree of correction need individual assessment. Neither indication means every cause of a dark or tired-looking under-eye area can be treated with filler.
Lips and Lines Around the Mouth
Belotero Intense (+) has a U.S. lip augmentation indication. Restylane Silk and Kysse have lip and specified perioral wrinkle indications. Merz also discusses Balance (+) for lines around the mouth, but clinicians should check the specific U.S. instructions rather than assume its approved wording matches Silk or Kysse.
Folds, Cheeks, and Midface
Balance (+) and several Restylane products address specified facial wrinkles and folds. Belotero Volume (+), Restylane Lyft, and Restylane Contour have cheek or midface uses.
Their approved placements and patient populations differ, so providers should compare the individual instructions before treating the area.
Temples and Chin
This is one of the clearer differences between the two portfolios. Galderma lists Restylane Contour for temple hollowing and Lyft and Defyne for specified chin indications.
The three Belotero products in this comparison do not list equivalent U.S. indications. Any indication remains subject to the full product label and individual patient assessment.
Which Lasts Longer: Belotero or Restylane?
There is no reliable brand-wide winner on duration. Merz states that Balance (+) and Volume (+) can last up to 18 months and Intense (+) up to 12 months. The Balance (+) 18-month statement has a specific study qualification, and these figures do not apply to every patient or treatment area.
Restylane duration also varies by product and treatment site. Providers should compare a named product’s published data rather than assume every Restylane syringe lasts the same length of time.
The FDA explains that the duration of a filler effect depends on the material and where it is injected. A manufacturer’s duration claim reflects a particular product, study, and use rather than an expected result for every patient.
Safety, Recovery, and Cost Considerations
Both families contain HA, and both can cause swelling, bruising, tenderness, and lumps. Serious complications are uncommon but possible.
The FDA dermal filler guidance warns that filler entering a blood vessel can cause tissue death, visual injury including blindness, or stroke. A trained clinician should review the relevant label, contraindications, medical history, and anatomy before treatment. The possibility of using hyaluronidase for an HA filler does not eliminate these risks.
No universal price comparison is useful because costs depend on the exact product, treatment plan, location, and provider. For clinics, wholesale price is only one part of the calculation. Expiry, expected use, training, and storage conditions also matter.
Handling rules vary by SKU. For example, Belotero Balance (+) labeling calls for storage at room temperature up to 25°C (77°F), away from heat, without freezing. A universal 2–8°C rule would therefore be incorrect for this product.
The Belotero vs Restylane provider comparison should also consider the clinician’s experience with the specific product, its approved indication, and the source of the syringe. Clinics buying fillers should confirm that the supplier’s route is authorized for U.S. products, then check the labeling, lot number, expiry, and condition on receipt.
Belotero or Restylane: Which Is Better?
Whether Belotero or Restylane is better depends first on the treatment goal.
For temple hollowing or a specified chin indication, the named Restylane products have a clear U.S.-label advantage over the three Belotero products discussed here. For under-eye hollows, lips, folds, and midface volume, both families offer indicated options.
The final choice should consider the specific product label, anatomy, treatment plan, patient characteristics, and clinician’s experience. Neither filler family can reasonably be considered superior for every patient or treatment area.
Ordering Fillers for Your Practice
Licensed medical practices can source professional-use aesthetic products through DeWitt Pharma, a Dallas-based, family-owned medical supplier serving licensed professionals nationwide. Professional credentials are verified as part of the ordering process.
Practices comparing filler options can view DeWitt Pharma’s full product catalog to explore available aesthetic injectables and other clinical supplies.
Final Thoughts on the Belotero vs Restylane Filler Comparison
Providers should compare specific products rather than brand stereotypes or broad duration claims. Approved indications, injection guidance, patient anatomy, clinical experience, and treatment goals should ultimately guide product selection.
Frequently Asked Questions
What is the main difference between Belotero and Restylane?
The differences between Belotero and Restylane come down to their individual gels, technologies, and approved uses. The Belotero products covered here use Merz’s CPM technology, while the Restylane family includes Galderma’s NASHA and XpresHAn products. Restylane also has named U.S. indications for temples and specified chin uses that the three Belotero products in this comparison do not.
Which option lasts longer, Belotero or Restylane?
Neither brand has one universal duration. Merz reports results lasting up to 18 months for Balance (+) and Volume (+), and up to 12 months for Intense (+), subject to product- and study-specific qualifications. Restylane duration also varies by individual product and treatment area. Providers should compare the published data for the specific fillers being considered rather than treating either brand as universally longer lasting.
How do treatment goals affect product choice?
Belotero and Restylane treatment areas overlap for under-eye hollows, lips, folds, and midface correction. The specific product’s approved use, patient anatomy, and treatment plan matter more than the brand alone. Restylane Contour also has a temple indication, while Lyft and Defyne have specified chin indications that the three Belotero products compared here do not.
Which product is better for first-time patients?
Neither Belotero nor Restylane is automatically better simply because a patient is receiving filler for the first time. Product selection should follow an assessment of treatment goals, anatomy, tissue characteristics, prior procedures, contraindications, and potential risks. A trained clinician can then select an appropriate product and treatment approach.
How do injection techniques differ between these products?
Injection technique depends on the individual filler and its indication rather than the brand alone. Belotero Intense (+), for example, has a lip indication with specified submucosal or subcutaneous placement, while Volume (+) has a deep midface indication. Providers should follow the current instructions for use and appropriate product-specific training.
What safety factors should providers compare?
Providers should compare each product’s labeled use, contraindications, injection guidance, patient history, and their own training with the product. Both filler families carry a risk of serious vascular complications despite their shared HA composition. Clinics should also verify the identity, lot number, expiry, condition, and provenance of the exact product before use.
How do wholesale costs affect product selection?
Clinics should compare pricing for the specific products they expect to use along with expiry, expected treatment volume, storage requirements, and training needs. A lower syringe price may offer little value if the product does not match the clinic’s typical treatment cases. Patient-facing treatment costs also depend on factors beyond the wholesale price of the filler.
Can both products be stocked in one clinic?
Yes. A clinic may stock products from both families when each fills a defined treatment need. Each filler should still be evaluated individually for its approved indications, inventory requirements, storage and handling instructions, and expected use within the practice.
What patient factors influence the final choice?
Anatomy, skin and tissue characteristics, prior filler, medical history, treatment goals, and patient preferences can all influence product selection. Understanding how specific Belotero and Restylane HA gels differ helps inform the decision, but it does not replace an individual clinical assessment.
Where can clinics order verified products safely?
Clinics should purchase through the manufacturer or a distribution route the manufacturer confirms for U.S. supply. On receipt, practices should verify the product label, lot number, expiry, packaging condition, and applicable storage requirements before use.
